title: New data on ONTARGET: more confusion?
authors.forename: Carlos
authors.initials: C
authors.lastname: Escobar
authors.forename: Rocio
authors.initials: R
authors.lastname: Echarri
authors.forename: Vivencio
authors.initials: V
authors.lastname: Barrios
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects* / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D001565:Benzoates / Q000009:adverse effects* / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D015337:Multicenter Studies as Topic; D017257:Ramipril / Q000009:adverse effects* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000077333:Telmisartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D017257:Ramipril; D000077333:Telmisartan